Literature DB >> 25579593

Monitoring RNA unwinding by the transcription termination factor Rho from Mycobacterium tuberculosis.

François D'Heygère1, Annie Schwartz, Franck Coste, Bertrand Castaing, Marc Boudvillain.   

Abstract

Transcription termination factor Rho is a ring-shaped, homo-hexamieric RNA translocase that dissociates transcription elongation complexes and transcriptional RNA-DNA duplexes (R-loops) in bacteria. The molecular mechanisms underlying these biological functions have been essentially studied with Rho enzymes from Escherichia coli or close Gram-negative relatives. However, phylo-divergent Rho factors may have distinct properties. Here, we describe methods for the preparation and in vitro characterization (ATPase and helicase activities) of the Rho factor from Mycobacterium tuberculosis, a specimen with uncharacteristic molecular and enzymatic features. These methods set the stage for future studies aimed at better defining the diversity of enzymatic properties of Rho across the bacterial kingdom.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25579593     DOI: 10.1007/978-1-4939-2214-7_18

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  ATP-dependent motor activity of the transcription termination factor Rho from Mycobacterium tuberculosis.

Authors:  François D'Heygère; Annie Schwartz; Franck Coste; Bertrand Castaing; Marc Boudvillain
Journal:  Nucleic Acids Res       Date:  2015-05-20       Impact factor: 16.971

2.  Mycobacterium smegmatis HelY Is an RNA-Activated ATPase/dATPase and 3'-to-5' Helicase That Unwinds 3'-Tailed RNA Duplexes and RNA:DNA Hybrids.

Authors:  Maria Loressa Uson; Heather Ordonez; Stewart Shuman
Journal:  J Bacteriol       Date:  2015-07-13       Impact factor: 3.490

3.  Cryo-EM structure of transcription termination factor Rho from Mycobacterium tuberculosis reveals bicyclomycin resistance mechanism.

Authors:  Emmanuel Saridakis; Rishi Vishwakarma; Josephine Lai-Kee-Him; Kevin Martin; Isabelle Simon; Martin Cohen-Gonsaud; Franck Coste; Patrick Bron; Emmanuel Margeat; Marc Boudvillain
Journal:  Commun Biol       Date:  2022-02-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.